EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients

Wenjing Zhou, Mengyuan Song, Jiajia Song, Litin You, Yi Zhu, Hao Chen, Juan Zhou

Journal of Cancer Research and Clinical Oncology · 28.06.2026 · 152 (7)

DOI: 10.1007/s00432-026-06554-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 28.06.2026. Verfasst von Wenjing Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating, Biomarkers, Tumor. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative recurrence and metastasis constitute critical obstacles for resected non-small cell lung cancer (NSCLC) patients, and reliable predictive biomarkers are still scarce. This study aimed to evaluate whether folate receptor-positive CTC (FR + CTC) predicts postoperative progressive disease (PD) in stage I–IIIA NSCLC and to explore noninvasive biomarkers for high-risk patients.

Method

We retrospectively enrolled stage I–IIIA NSCLC patients undergoing radical resection from 2018 to 2021. Perioperative blood samples were collected for FR + CTC detection. PD-related risk factors were analyzed to establish a postoperative prognostic model.

Result

In total, 171 NSCLC patients were enrolled. Stage III disease had higher preoperative FR⁺CTC positivity than stage I–II (69.39% vs. 52.46%, P = 0.043). Male gender, smoke, squamous histology and stage III correlated with elevated postoperative FR⁺CTC positivity (all P < 0.05). Among 152 patients for survival analysis, 36 developed 36‑month PD. Multivariate Cox confirmed postoperative FR⁺CTC positivity (HR = 2.25, P = 0.018) and stage III (HR = 3.43, P = 0.005) as independent PD predictors. FR⁺CTC conversion from preoperative negative to postoperative positive conferred the highest PD risk and shortened PFS.

Conclusion

Postoperative FR + CTC positive and TNM stage III were independent risk factors for 36 months PD in NSCLC patients after radical resection. Postoperative FR⁺CTC positivity correlated with shortened PFS and effectively predicted postoperative PD. Conversion from preoperative FR⁺CTC negativity to postoperative positivity conferred the highest progression risk. Perioperative FR⁺CTC detection and dynamic monitoring are promising liquid biopsy biomarkers for postoperative progression prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplastic Cells, CirculatingBiomarkers, TumorHumansMaleFemaleRetrospective StudiesAgedMiddle AgedDisease ProgressionPrognosisPredictive Value of TestsNeoplasm Staging

Stichwörter der Autor:innen

Folate receptor-positve circulating tumor cellsNon-small cell lung cancerProgressive disease

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Laboratory Medicine, General Healthcare Chengfei Hospital, University, Chengdu, 610041, China.
  • Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China. zhoujuan39@wchscu.cn.
  • Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, China. zhoujuan39@wchscu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, W., Song, M., Song, J., You, L., Zhu, Y., Chen, H., & Zhou, J. (2026). Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients. Journal of Cancer Research and Clinical Oncology, 152(7). https://doi.org/10.1007/s00432-026-06554-1

Vancouver

Zhou W, Song M, Song J, You L, Zhu Y, Chen H, et al. Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients. Journal of Cancer Research and Clinical Oncology. 2026;152(7). doi:10.1007/s00432-026-06554-1

BibTeX
@article{Zhou2026,
  author = {Zhou, Wenjing and Song, Mengyuan and Song, Jiajia and You, Litin and Zhu, Yi and Chen, Hao and Zhou, Juan},
  title = {Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2026},
  volume = {152},
  number = {7},
  doi = {10.1007/s00432-026-06554-1}
}
Kostenlos starten →